- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 30.01. | Greek shipping execs' SPAC Stellar V Capital prices $150 million IPO | ||
| 30.01. | Insulin delivery device maker Beta Bionics prices further upsized IPO at $17, the high end of the upwardly revised range | ||
| 29.01. | Inflammation biotech Apimeds Pharmaceuticals ups deal size by 74% ahead of $20 million IPO | ||
| 29.01. | Private equity firm's SPAC Cartesian Growth III files for a $200 million IPO | ||
| 29.01. | Financial services SPAC FG Merger II prices $80 million IPO | ||
| 29.01. | SPAC Gesher Acquisition II files for a $125 million IPO, targeting Israeli businesses | ||
| 29.01. | Singapore-based cable laying firm Vistek files and sets terms for $10 million US IPO | ||
| 28.01. | Chinese business services provider QMSK Technology files and sets terms for an $8 million US IPO | ||
| 28.01. | Insulin delivery device maker Beta Bionics increases deal size by 47% ahead of $165 million IPO | ||
| 28.01. | Malaysian software firm Sagtec Global sets terms for $7 million US IPO | ||
| 28.01. | Cement production carve-out Titan America sets terms for $396 million IPO | ||
| 28.01. | Pork producer Smithfield Foods prices downsized IPO well below the range at $20 | ||
| 28.01. | SPAC Drugs Made In America Acquisition prices $200 million IPO, targeting pharma in the US | ||
| 27.01. | Obesity biotech Metsera sets terms for $275 million IPO | ||
| 27.01. | Stone products distributor Capstone Holding sets terms for $5 million Nasdaq uplisting | ||
| 27.01. | Precision medicine biotech Maze Therapeutics sets terms for $125 million IPO | ||
| 25.01. | US IPO Week Ahead: Meat, oil, and more set to debut in 4 IPO week | ||
| 25.01. | US IPO Weekly Recap: Venture Global prices a pared-down IPO as more sizable deals join the pipeline | ||
| 25.01. | Chinese consumer products retailer Softto files and sets terms for a $15 million US IPO | ||
| 24.01. | Financials SPAC Soulpower Acquisition files for a $200 million IPO | ||
| 24.01. | Hong Kong-listed biotech Ascentage Pharma prices US IPO at $17.25 | ||
| 24.01. | LNG exporter Venture Global prices IPO at $25, the midpoint of the downwardly revised range, in the largest energy listing in over a decade | ||
| 24.01. | Metabolic disease biotech Aardvark Therapeutics files for a $100 million IPO | ||
| 23.01. | India-based furniture distributor HTL Capital withdraws $19 million US IPO | ||
| 23.01. | Industrial power system operator One Power files for a $100 million IPO |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
